Genomewide m6A mapping uncovers dynamic changes in the m6A epitranscriptome of cisplatin-treated apoptotic HeLa cells.

Related articles

Press Release

07
24
24

Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic Products 

Eclipse Bioinnovations, Inc. (Eclipsebio), the leading RNA genomics company developing and commercializing novel, data-driven technologies and analyses that interrogate RNA, today announced the launch of its proprietary eMERGE™ platform.

read more

eBlogs

06
14
24

Characterization is key: how to evaluate mRNA therapeutic safety and efficacy

Before release into the clinic mRNA therapeutics need comprehensive characterization. In this eBlog we review key quality attributes of mRNA therapeutics.

read more

eBlogs

04
11
24

Discovering miRNA regulation with miR-eCLIP

miRNAs are key regulators of expression and translation, however identifying where and how they bind can be a challenge. In this eBlog we reveal how miR-eCLIP can be used to directly profile miRNA activity.

read more

eBlogs

02
26
24

Successful mRNA therapeutic design: optimizing for stability and translation

mRNA therapeutics are revolutionizing medicine but the design of an effective RNA can be challenging. In this eBlog we review key design factors.

read more